bevacizumab,cetuximab
roche,eli lilly
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'fire-4']
fire-4: more data to support repeated liquid ngs testing in mcrc. anti-egfr therapy creates a selective pressure over time for resistant clones. #asco23 #crcsm 
GI Oncologist at @IUCancerCenter. @uw_hemeoncpc and @UChicagomed alum. Tweets are my own.